Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.
Bladder cancer
Cystectomy
Ileal neobladder
Quality of life
Urinary incontinence
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
28
09
2018
accepted:
13
01
2019
pubmed:
1
2
2019
medline:
18
3
2020
entrez:
1
2
2019
Statut:
ppublish
Résumé
To objectively quantify continence rates and to correlate continence outcomes with health-related quality of life (HRQOL) after radical cystectomy and orthotopic ileal neobladder (ONB). Questionnaires were sent to 244 patients who underwent radical cystectomy with ONB between 2004 and 2015, and information about the current continence status was retrieved. To objectify postoperative urine loss, daytime and nocturnal pad tests were performed. Continence was defined as need of up to one safety pad. HRQOL was assessed using EORTC QLQ-C30 scoring with global health status being the primary endpoint. Statistical analysis included Fisher's test, Mann-Whitney U test, Pearson's rank correlation, and binary regression models (p < 0.05). 178 patients (73.0%) answered the QLQ-C30 questionnaires and were included in the study. Median follow-up was 61 months. Median daytime pad use was 1 and median daily urine loss based on pad testing was 4.0 g, leading to a daytime continence rate of 48.5%. Continence had a significant impact on postoperative HRQOL (p = 0.017). ICIQ-SF score (p = 0.001, OR = 0.805) and need for condom catheter during nighttime (p = 0.015, OR = 0.123) were independent predictors for worse HRQOL outcomes based on global health status. A history of pelvic floor muscle training was an independent predictor of increased HRQOL (p = 0.009, OR = 10.459). Need of condom urinals and higher ICIQ-SF scores are independent predictors for worse HRQOL outcomes. We show significant beneficial effects of pelvic floor muscle training on patients' HRQOL.
Identifiants
pubmed: 30701335
doi: 10.1007/s00345-019-02643-8
pii: 10.1007/s00345-019-02643-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2385-2392Références
Eur J Surg Oncol. 2016 Mar;42(3):343-60
pubmed: 26620844
Int Urol Nephrol. 2011 Sep;43(3):749-54
pubmed: 21053073
JAMA. 2011 Jan 12;305(2):151-9
pubmed: 21224456
Int J Urol. 2014 Sep;21(9):887-92
pubmed: 24684718
J Urol. 1988 Jan;139(1):39-42
pubmed: 3336101
Qual Life Res. 2013 Dec;22(10):2685-91
pubmed: 23532341
Neurourol Urodyn. 2004;23(4):322-30
pubmed: 15227649
J Urol. 2006 Jul;176(1):161-6
pubmed: 16753394
Eur J Cancer. 2001 Jul;37(11):1331-4
pubmed: 11435060
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Curr Opin Urol. 2013 Sep;23(5):479-86
pubmed: 23851385
Eur Urol. 2014 Apr;65(4):778-92
pubmed: 24373477
J Urol. 2017 Jan;197(1):210-215
pubmed: 27506691
Urol Int. 2015;94(2):125-32
pubmed: 25427689
Int Braz J Urol. 2016 Nov-Dec;42(6):1109-1120
pubmed: 24893915
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
pubmed: 24399786
Urology. 2015 Nov;86(5):974-9
pubmed: 26291562